Login Register Cart 0
Generic placeholder image

Current Vascular Pharmacology

Editor-in-Chief

ISSN (Print): 1570-1611
ISSN (Online): 1875-6212

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Perspective

COVID-19 and Kidney Disease: A Clinical Perspective

Author(s): Panagiotis Theofilis, Aikaterini Vordoni and Rigas G. Kalaitzidis*

Volume 20, Issue 4, 2022

Published on: 22 June, 2022

Page: [321 - 325] Pages: 5

DOI: 10.2174/1570161120666220513103007

Abstract

Coronavirus disease-19 (COVID-19), caused by severe acute respiratory syndrome Coronavirus- 2 (SARS-CoV-2), has caused a global pandemic with high morbidity and mortality. The presence of several comorbidities has been associated with a worse prognosis, with chronic kidney disease being a critical risk factor. Regarding COVID-19 complications, other than classical pneumonia and thromboembolism, acute kidney injury (AKI) is highly prevalent and represents a poor prognostic indicator linked to increased disease severity and mortality. Its pathophysiology is multifactorial, revolving around inflammation, endothelial dysfunction, and activation of coagulation, while the direct viral insult of the kidney remains a matter of controversy. Indirectly, COVID-19 AKI may stem from sepsis, volume depletion, and administration of nephrotoxic agents, among others. Several markers have been proposed for the early detection of COVID-19 AKI, including blood and urinary inflammatory and kidney injury biomarkers, while urinary SARS-CoV-2 load may also be an early prognostic sign. Concerning renal replacement therapy (RRT), general principles apply to COVID-19 AKI, but sudden RRT surges may mandate adjustments in resources. Following an episode of COVID-19 AKI, there is a gradual recovery of kidney function, with pre-existing renal impairment and high serum creatinine at discharge being associated with kidney disease progression and long-term dialysis dependence. Finally, kidney transplant recipients represent a special patient category with increased susceptibility to COVID- 19 and subsequent high risk of severe disease progression. Rates of mortality, AKI, and graft rejection are significantly elevated in the presence of COVID-19, highlighting the need for prevention and careful management of the disease in this subgroup.

Keywords: COVID-19, acute kidney injury, chronic kidney disease, renal replacement therapy, kidney transplantation, SARSCoV- 2.

« Previous Next »
Graphical Abstract

[1]
Kaye AD, Okeagu CN, Pham AD, et al. Economic impact of COVID-19 pandemic on healthcare facilities and systems: International perspectives. Best Pract Res Clin Anaesthesiol 2021; 35(3): 293-306.
[http://dx.doi.org/10.1016/j.bpa.2020.11.009] [PMID: 34511220]
[2]
Sagris M, Theofilis P, Antonopoulos AS, et al. Inflammatory mechanisms in COVID-19 and atherosclerosis: Current pharmaceutical perspectives. Int J Mol Sci 2021; 22(12): 6607.
[http://dx.doi.org/10.3390/ijms22126607] [PMID: 34205487]
[3]
Theofilis P, Sagris M, Oikonomou E, et al. Inflammatory mechanisms contributing to endothelial dysfunction. Biomedicines 2021; 9(7): 781.
[http://dx.doi.org/10.3390/biomedicines9070781] [PMID: 34356845]
[4]
Levi M, Thachil J, Iba T, Levy JH. Coagulation abnormalities and thrombosis in patients with COVID-19. Lancet Haematol 2020; 7(6): e438-40.
[http://dx.doi.org/10.1016/S2352-3026(20)30145-9] [PMID: 32407672]
[5]
Theofilis P, Sagris M, Antonopoulos AS, Oikonomou E, Tsioufis C, Tousoulis D. Inflammatory mediators of platelet activation: Focus on atherosclerosis and COVID-19. Int J Mol Sci 2021; 22(20): 11170.
[http://dx.doi.org/10.3390/ijms222011170] [PMID: 34681830]
[6]
Lazaros G, Oikonomou E, Theofilis P, et al. The impact of COVID-19 pandemic on adult cardiac surgery procedures. Hellenic J Cardiol 2021; 62(3): 231-3.
[http://dx.doi.org/10.1016/j.hjc.2020.07.001] [PMID: 32679176]
[7]
Oikonomou E, Aznaouridis K, Barbetseas J, et al. Hospital attendance and admission trends for cardiac diseases during the COVID-19 outbreak and lockdown in Greece. Public Health 2020; 187: 115-9.
[http://dx.doi.org/10.1016/j.puhe.2020.08.007] [PMID: 32949881]
[8]
Chen G, Zhou Y, Xia J, et al. When the COVID-19 pandemic changed the follow-up landscape of chronic kidney disease: A survey of real-world nephrology practice. Ren Fail 2020; 42(1): 733-9.
[http://dx.doi.org/10.1080/0886022X.2020.1798783] [PMID: 32718215]
[9]
Clark A, Jit M, Warren-Gash C, et al. Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: A modelling study. Lancet Glob Health 2020; 8(8): e1003-17.
[http://dx.doi.org/10.1016/S2214-109X(20)30264-3] [PMID: 32553130]
[10]
Williamson EJ, Walker AJ, Bhaskaran K, et al. Factors associated with COVID-19-related death using OpenSAFELY. Nature 2020; 584(7821): 430-6.
[http://dx.doi.org/10.1038/s41586-020-2521-4] [PMID: 32640463]
[11]
Thakur B, Dubey P, Benitez J, et al. A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19. Sci Rep 2021; 11(1): 8562.
[http://dx.doi.org/10.1038/s41598-021-88130-w] [PMID: 33879826]
[12]
Yang X, Jin Y, Li R, Zhang Z, Sun R, Chen D. Prevalence and impact of acute renal impairment on COVID-19: A systematic review and meta-analysis. Crit Care 2020; 24(1): 356.
[http://dx.doi.org/10.1186/s13054-020-03065-4] [PMID: 32552872]
[13]
Hilbrands LB, Duivenvoorden R, Vart P, et al. COVID-19-related mortality in kidney transplant and dialysis patients: Results of the ERACODA collaboration. Nephrol Dial Transplant 2020; 35(11): 1973-83.
[http://dx.doi.org/10.1093/ndt/gfaa261] [PMID: 33151337]
[14]
Nopsopon T, Kittrakulrat J, Takkavatakarn K, Eiamsitrakoon T, Kanjanabuch T, Pongpirul K. COVID-19 in end-stage renal disease patients with renal replacement therapies: A systematic review and meta-analysis. PLoS Negl Trop Dis 2021; 15(6): e0009156.
[http://dx.doi.org/10.1371/journal.pntd.0009156] [PMID: 34129609]
[15]
Ahmed W, Al Obaidli AAK, Joseph P, et al. Outcomes of patients with end stage kidney disease on dialysis with COVID-19 in Abu Dhabi, United Arab Emirates; from PCR to antibody. BMC Nephrol 2021; 22(1): 198.
[http://dx.doi.org/10.1186/s12882-021-02378-y] [PMID: 34039299]
[16]
Rastad H, Ejtahed HS, Shafiee G, et al. The risk factors associated with COVID-19-Related death among patients with end-stage renal disease. BMC Nephrol 2021; 22(1): 33.
[http://dx.doi.org/10.1186/s12882-020-02221-w] [PMID: 33468081]
[17]
Navarrete JE, Tong DC, Cobb J, et al. Epidemiology of COVID-19 infection in hospitalized end-stage kidney disease patients in a predominantly African-American population. Am J Nephrol 2021; 52(3): 190-8.
[http://dx.doi.org/10.1159/000514752] [PMID: 33827078]
[18]
Brogan M, Ross MJ. The impact of chronic kidney disease on outcomes of patients with COVID-19 admitted to the intensive care unit. Nephron 2022; 146(1): 67-71.
[http://dx.doi.org/10.1159/000519530] [PMID: 34634789]
[19]
Anand S, Montez-Rath ME, Han J, et al. SARS-CoV-2 vaccine antibody response and breakthrough infection in patients receiving dialysis. Ann Intern Med 2022; 175(3): 371-8.
[http://dx.doi.org/10.7326/M21-4176] [PMID: 34904856]
[20]
Wang L, Li X, Chen H, et al. Coronavirus disease 19 infection does not result in acute kidney injury: An analysis of 116 hospitalized patients from Wuhan, China. Am J Nephrol 2020; 51(5): 343-8.
[http://dx.doi.org/10.1159/000507471] [PMID: 32229732]
[21]
Xia T, Zhang W, Xu Y, et al. Early kidney injury predicts disease progression in patients with COVID-19: A cohort study. BMC Infect Dis 2021; 21(1): 1012.
[http://dx.doi.org/10.1186/s12879-021-06576-9] [PMID: 34579666]
[22]
Sullivan MK, Lees JS, Drake TM, et al. Acute kidney injury in patients hospitalized with COVID-19 from the ISARIC WHO CCP-UK Study: A prospective, multicentre cohort study. Nephrol Dial Transplant 2022; 37(2): 271-84.
[http://dx.doi.org/10.1093/ndt/gfab303] [PMID: 34661677]
[23]
Wan YI, Bien Z, Apea VJ, et al. Acute kidney injury in COVID-19: Multicentre prospective analysis of registry data. Clin Kidney J 2021; 14(11): 2356-64.
[http://dx.doi.org/10.1093/ckj/sfab071] [PMID: 34751235]
[24]
Naser MN, Al-Ghatam R, Darwish AH, et al. Risk factors, predictions, and progression of acute kidney injury in hospitalized COVID-19 patients: An observational retrospective cohort study. PLoS One 2021; 16(9): e0257253.
[http://dx.doi.org/10.1371/journal.pone.0257253] [PMID: 34587189]
[25]
Jewell PD, Bramham K, Galloway J, et al. COVID-19-related acute kidney injury; incidence, risk factors and outcomes in a large UK cohort. BMC Nephrol 2021; 22(1): 359.
[http://dx.doi.org/10.1186/s12882-021-02557-x] [PMID: 34719384]
[26]
Ng JH, Hirsch JS, Hazzan A, et al. Outcomes among patients hospitalized with COVID-19 and acute kidney injury. Am J Kidney Dis 2021; 77(2): 204-215.e1.
[http://dx.doi.org/10.1053/j.ajkd.2020.09.002] [PMID: 32961245]
[27]
Cau A, Cheng MP, Lee T, et al. Acute kidney injury and renal replacement therapy in COVID-19 versus other respiratory viruses: A systematic review and meta-analysis. Can J Kidney Health Dis 2021; 8: 20543581211052185.
[http://dx.doi.org/10.1177/20543581211052185] [PMID: 34733538]
[28]
Alenezi FK, Almeshari MA, Mahida R, Bangash MN, Thickett DR, Patel JM. Incidence and risk factors of acute kidney injury in COVID-19 patients with and without acute respiratory distress syndrome (ARDS) during the first wave of COVID-19: A systematic review and Meta-Analysis. Ren Fail 2021; 43(1): 1621-33.
[http://dx.doi.org/10.1080/0886022X.2021.2011747] [PMID: 34882508]
[29]
Toth-Manikowski SM, Caldwell J, Joo M, et al. Sex-related differences in mortality, acute kidney injury, and respiratory failure among critically ill patients with COVID-19. Medicine (Baltimore) 2021; 100(50): e28302.
[http://dx.doi.org/10.1097/MD.0000000000028302] [PMID: 34918709]
[30]
Kilis-Pstrusinska K, Akutko K, Braksator J, et al. Kidney dysfunction and its progression in patients hospitalized duo to COVID-19: Contribution to the clinical course and outcomes. J Clin Med 2021; 10(23): 5522.
[http://dx.doi.org/10.3390/jcm10235522] [PMID: 34884225]
[31]
Kudose S, Batal I, Santoriello D, et al. Kidney biopsy findings in patients with COVID-19. J Am Soc Nephrol 2020; 31(9): 1959-68.
[http://dx.doi.org/10.1681/ASN.2020060802] [PMID: 32680910]
[32]
Puelles VG, Lütgehetmann M, Lindenmeyer MT, et al. Multiorgan and renal tropism of SARS-CoV-2. N Engl J Med 2020; 383(6): 590-2.
[http://dx.doi.org/10.1056/NEJMc2011400] [PMID: 32402155]
[33]
May RM, Cassol C, Hannoudi A, et al. A multi-center retrospective cohort study defines the spectrum of kidney pathology in Coronavirus 2019 Disease (COVID-19). Kidney Int 2021; 100(6): 1303-15.
[http://dx.doi.org/10.1016/j.kint.2021.07.015] [PMID: 34352311]
[34]
Nadim MK, Forni LG, Mehta RL, et al. COVID-19-associated acute kidney injury: Consensus report of the 25th Acute Disease Quality Initiative (ADQI) Workgroup. Nat Rev Nephrol 2020; 16(12): 747-64.
[http://dx.doi.org/10.1038/s41581-020-00356-5] [PMID: 33060844]
[35]
Joannidis M, Forni LG, Klein SJ, et al. Lung-kidney interactions in critically ill patients: Consensus report of the Acute Disease Quality Initiative (ADQI) 21 Workgroup. Intensive Care Med 2020; 46(4): 654-72.
[http://dx.doi.org/10.1007/s00134-019-05869-7] [PMID: 31820034]
[36]
Karras A, Livrozet M, Lazareth H, et al. Proteinuria and clinical outcomes in hospitalized COVID-19 patients: A retrospective single-center study. Clin J Am Soc Nephrol 2021; 16(4): 514-21.
[http://dx.doi.org/10.2215/CJN.09130620] [PMID: 33661756]
[37]
Yildirim C, Ozger HS, Yasar E, et al. Early predictors of acute kidney injury in COVID-19 patients. Nephrology (Carlton) 2021; 26(6): 513-21.
[http://dx.doi.org/10.1111/nep.13856] [PMID: 33502771]
[38]
Xu K, Shang N, Levitman A, et al. Elevated neutrophil gelatinase-associated lipocalin is associated with the severity of kidney injury and poor prognosis of patients with COVID-19. Kidney Int Rep 2021; 6(12): 2979-92.
[http://dx.doi.org/10.1016/j.ekir.2021.09.005] [PMID: 34642645]
[39]
Menez S, Moledina DG, Thiessen-Philbrook H, et al. Prognostic significance of urinary biomarkers in patients hospitalized with COVID-19. Am J Kidney Dis 2022; 79(2): 257-267.e1.
[http://dx.doi.org/10.1053/j.ajkd.2021.09.008] [PMID: 34710516]
[40]
Gradin A, Andersson H, Luther T, et al. Urinary cytokines correlate with acute kidney injury in critically ill COVID-19 patients. Cytokine 2021; 146: 155589.
[http://dx.doi.org/10.1016/j.cyto.2021.155589] [PMID: 34161857]
[41]
Sancho Ferrando E, Hanslin K, Hultström M, Larsson A, Frithiof R, Lipcsey M. Soluble TNF receptors predict acute kidney injury and mor-tality in critically ill COVID-19 patients: A prospective observational study. Cytokine 2022; 149: 155727.
[http://dx.doi.org/10.1016/j.cyto.2021.155727] [PMID: 34628127]
[42]
Bülow Anderberg S, Lipcsey M, Hultström M, Eriksson AK, Venge P, Frithiof R. Systemic human neutrophil lipocalin associates with severe acute kidney injury in SARS-CoV-2 pneumonia. J Clin Med 2021; 10(18): 4144.
[http://dx.doi.org/10.3390/jcm10184144] [PMID: 34575252]
[43]
Laudanski K, Okeke T, Hajj J, et al. Longitudinal urinary biomarkers of immunological activation in covid-19 patients without clinically apparent kidney disease versus acute and chronic failure. Sci Rep 2021; 11(1): 19675.
[http://dx.doi.org/10.1038/s41598-021-99102-5] [PMID: 34608231]
[44]
Caceres PS, Savickas G, Murray SL, et al. High SARS-CoV-2 viral load in urine sediment correlates with acute kidney injury and poor COVID-19 outcome. J Am Soc Nephrol 2021; 32(10): 2517-28.
[http://dx.doi.org/10.1681/ASN.2021010059] [PMID: 34088853]
[45]
Burke E, Haber E, Pike CW, Sonti R. Outcomes of renal replacement therapy in the critically ill with COVID-19. Med Intensiva 2021; 45(6): 325-31.
[http://dx.doi.org/10.1016/j.medin.2021.02.004]
[46]
Hsu CM, Gupta S, Tighiouart H, et al. Kidney recovery and death in critically Ill patients With COVID-19-associated acute kidney injury treated with dialysis: The STOP-COVID cohort study. Am J Kidney Dis 2022; 79(3): 404-416.e1.
[http://dx.doi.org/10.1053/j.ajkd.2021.11.004] [PMID: 34871701]
[47]
Hertzberg D, Renberg M, Nyman J, Bell M, Rimes Stigare C. Experiences of renal replacement therapy delivery in swedish intensive care units during the COVID-19 pandemic. Blood Purif 2022; 51(7): 584-9.
[PMID: 34614497]
[48]
Khadzhynov D, von dem Berge U, Muench F, et al. Efficacy and complications of regional citrate anticoagulation during continuous renal replacement therapy in critically ill patients with COVID-19. J Crit Care 2022; 67: 126-31.
[http://dx.doi.org/10.1016/j.jcrc.2021.10.010] [PMID: 34768173]
[49]
Sohaney R, Shaikhouni S, Ludwig JT, et al. Continuous renal replacement therapy among patients with COVID-19 and acute kidney injury. Blood Purif 2022; 51(9): 660-7.
[http://dx.doi.org/10.1159/000518713] [PMID: 34727545]
[50]
Theofilis P, Vordoni A, Koukoulaki M, Vlachopanos G, Kalaitzidis RG. Dyslipidemia in chronic kidney disease: Contemporary concepts and future therapeutic perspectives. Am J Nephrol 2021; 52(9): 693-701.
[http://dx.doi.org/10.1159/000518456] [PMID: 34569479]
[51]
Zhang NH, Cheng YC, Luo R, Zhang CX, Ge SW, Xu G. Recovery of new-onset kidney disease in COVID-19 patients discharged from hospital. BMC Infect Dis 2021; 21(1): 397.
[http://dx.doi.org/10.1186/s12879-021-06105-8] [PMID: 33926392]
[52]
Chand S, Kapoor S, Naqvi A, et al. Long-term follow up of renal and other acute organ failure in survivors of critical illness due to Covid-19. J Intensive Care Med 2021; 37(6): 73-42.
[http://dx.doi.org/10.1177/08850666211062582] [PMID: 34918990]
[53]
Melero R, Mijaylova A, Rodriguez-Benitez P, et al. Renal long-term outcome of critically ill COVID-19 patients with acute kidney failure and continuous renal replacement therapy. Clin Kidney J 2021; 14(11): 2449-50.
[http://dx.doi.org/10.1093/ckj/sfab150] [PMID: 34754443]
[54]
Groff D, Sun A, Ssentongo AE, et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: A systematic review. JAMA Netw Open 2021; 4(10): e2128568.
[http://dx.doi.org/10.1001/jamanetworkopen.2021.28568] [PMID: 34643720]
[55]
Bowe B, Xie Y, Xu E, Al-Aly Z. Kidney outcomes in long COVID. J Am Soc Nephrol 2021; 32(11): 2851-62.
[http://dx.doi.org/10.1681/ASN.2021060734] [PMID: 34470828]
[56]
Chen JJ, Kuo G, Lee TH, et al. Incidence of mortality, acute kidney injury and graft loss in adult kidney transplant recipients with coronavirus disease 2019: Systematic review and meta-analysis. J Clin Med 2021; 10(21): 5162.
[http://dx.doi.org/10.3390/jcm10215162] [PMID: 34768682]
[57]
Vinson AJ, Agarwal G, Dai R, et al. COVID-19 in solid organ transplantation: Results of the national COVID cohort collaborative. Transplant Direct 2021; 7(11): e775.
[http://dx.doi.org/10.1097/TXD.0000000000001234] [PMID: 34646938]
[58]
Jayant K, Reccia I, Bachul PJ, et al. The impact of COVID-19 on kidney transplant recipients in pre-vaccination and delta strain era: A systematic review and meta-analysis. J Clin Med 2021; 10(19): 4533.
[http://dx.doi.org/10.3390/jcm10194533] [PMID: 34640552]
[59]
Udomkarnjananun S, Kerr SJ, Townamchai N, et al. Mortality risk factors of COVID-19 infection in kidney transplantation recipients: A systematic review and meta-analysis of cohorts and clinical registries. Sci Rep 2021; 11(1): 20073.
[http://dx.doi.org/10.1038/s41598-021-99713-y] [PMID: 34625642]

Rights & Permissions Print Cite
Article Metrics
26
2
© 2024 Bentham Science Publishers | Privacy Policy